Blog Authors

Latest from Drug Injury Watch

October 2021 UK’s MHRA Xeljanz Action Follows September 2021 FDA Xeljanz Drug Safety Communication Update
 
(Posted by Tom Lamb at Drug Injury Watch)
 
On September 1, 2021, we posted this article, “Xeljanz: FDA Warnings Updated: There
Continue Reading Xeljanz Risks of Cardiovascular Events, as Well as Cancers, Lead to More Xeljanz Use Limitations

Reports of Rheumatoid Arthritis Patients on Xeljanz Experiencing Secondary Neurological Adverse Events
 
(Posted by Tom Lamb at Drug Injury Watch)
 
As we have written about previously, according to the FDA, some of the generally recognized Xeljanz side
Continue Reading Xeljanz: Drug-induced Peripheral Neuropathy as Possible Xeljanz Side Effect in 2 RA Patients

Bladder Cancer Drug Padcev is Linked to Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) in 2021
 
(Posted by Tom Lamb at Drug Injury Watch)
 
Padcev (enfortumab vedotin-ejfv), an injection drug for intravenous use, was approved by
Continue Reading Padcev Skin Reaction Side Effects SJS and TEN: From No Warning to "Black Box" in Less Than 2 Years

Two Recent Medical Articles on Vision Side Effects of Elmiron (pentosan polysulfate sodium, or PPS) for Interstitial Cystitis
 
(Posted by Tom Lamb at Drug Injury Watch)
 
Chronic use of Elmiron (pentosan polysulfate sodium, or PPS) for interstitial
Continue Reading Elmiron and Maculopathy: Increased Risk of Ocular Complications in Long-Term, High-Dose Elmiron Use

JAK Inhibitors Xeljanz, Olumiant, and Rinvoq Get Drug Label Changes and Drug Use Limitations in September 2021
 
(Posted by Tom Lamb at Drug Injury Watch)
 
On September 1, 2021, the FDA released this alerting news about the
Continue Reading Xeljanz: FDA Warnings Updated: There are Higher Rates of Blood Clots and Deaths for Both Doses of Xeljanz, Now

Consolidation of Tasigna Drug Injury Cases Involving Atherosclerosis-related Diseases and Medical Conditions
 
(Posted by Tom Lamb at Drug Injury Watch)
 
On August 12, 2021, the United States Judicial Panel on Multidistrict Litigation (JPML) created a new federal
Continue Reading Tasigna Lawsuits Federal Court MDL Order Issued in August 2021 After July 2021 JPML Hearing